Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

244.92 -4.10 (-1.65%)
Official Closing Price Updated: 7:00 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Resmed Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
What 6 Analyst Ratings Have To Say About ResMed
Via Benzinga
American Express To Rally Over 25%? Here Are 10 Other Analyst Forecasts For Tuesday
Wells Fargo raised the price target for Equity Residential (NYSE: EQR) from $62 to $69. Wells Fargo analyst James Feldman upgraded the stock from Equal-Weight to Overweight. Equity Residential shares... 
Via Benzinga
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
Mick Farrell might be kidding himself about the degree to which the popular weight-loss drugs will impact his company. 
Via The Motley Fool
Late-Summer Steals: 7 Stocks to Buy Before Fall
With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now. 
Via InvestorPlace
3 Growth Stocks That Can Soar 50%, According to Wall Street
Are these stocks the slam-dunk buys analysts think they are? 
Via The Motley Fool
The Latest Analyst Ratings for ResMed
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,000 Today
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 150 companies set new 52-week lows. 
Via Benzinga
Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble
With plenty of companies having their share prices corrected in August, it's time to shop for bargain stocks to buy on the dip. 
Via InvestorPlace
5 Blue-Chip Stocks AI Thinks Will Double Your Money by 2027
Blue-chip stocks are traditionally market laggards, but the MarketMaster AI is flashing major "buy" signals in these 5 names right now. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
ResMed's Earnings: A Preview
Via Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 5 Years
Via Benzinga
Looking Into ResMed's Recent Short Interest
Via Benzinga
2 Stocks That Could Grow Your Portfolio Over the Next Decade
These two promising stocks could help your portfolio grow steadily over the long term. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
Here's How Much $100 Invested In ResMed 20 Years Ago Would Be Worth Today
Via Benzinga
Peering Into ResMed's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry
ResMed Inc (NYSE: RMD) posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Via Benzinga
A Bullish Sign Appears On ResMed's Chart
Via Benzinga
ResMed Earnings Perspective: Return On Capital Employed
Via Benzinga
Electronic Arts, TD SYNNEX And 2 Other Stocks Insiders Are Selling
The Nasdaq index closed lower on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
What's Going On With ResMed Stock Today
ResMed Inc (NYSE: RMD) posted Q3 profits of $247.8 million, with adjusted EPS of $1.68, up from $1.32 a year ago, beating the consensus of $1.59. Revenues increased 29% to $1.12 billion, as continued... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.